A Huntingdon-based technology developer has been acquired by a sector-leading company in a bid to develop further technologies to give patients more control of their health.
Aseptika (Activ8rlives) has been taken over by Spirit INT, the parent company of British healthcare provider Spirit Healthcare.
Aseptika founder, Kevin Auton, said: “We are delighted to be joining the highly successful Spirit group of companies in delivering the new technologies, solutions and services needed to support the growing healthcare needs of the UK.”
It is hoped by bringing Aseptika into the Spirit family, it will be able to link the company’s self-monitoring solutions with Spirit’s cloud-based technology, CliniTouch Vie, to expand its offerings
Chief executive, Chris Barker said: “The Aseptika team has exceptional experience developing pioneering technology and we’re looking to grow this capability at its Cambridgeshire hub.With these skills, Spirit will be able to accelerate its programme of innovation.”
It is hoped that following the take over the technology provided by the companies will be able to help patients who have been recently diagnosed with respiratory problems to those with more complex needs, along with being living with Cystic Fibrosis.
“We look forward to bringing the wearable medical monitor BuddyWOTCH and the patented home-use test to detect bacterial chest infections to the market to support patients with severe respiratory conditions,” said Mr Auton.
Mr Barker added: “We’re innovating and growing fast so we can empower more patients across the UK. This significant acquisition is the second that we’ve made and we’re certainly on the hunt for more acquisition opportunities in the near future.”